A “dock, lock, and latch” Structural Model for a Staphylococcal Adhesin Binding to Fibrinogen

Gram-positive pathogens such as staphylococci contain multiple cell wall-anchored proteins that serve as an interface between the microbe and its environment. Some of these proteins act as adhesins and mediate bacterial attachment to host tissues. SdrG is a cell wall-anchored adhesin from Staphylococcus epidermidis that binds to the Bbeta chain of human fibrinogen (Fg) and is necessary and sufficient for bacterial attachment to Fg-coated biomaterials. Here, we present the crystal structures of the ligand binding region of SdrG as an apoprotein and in complex with a synthetic peptide analogous to its binding site in Fg. Analysis of the crystal structures, along with mutational studies of both the protein and of the peptide, reveals that SdrG binds to its ligand with a dynamic "dock, lock, and latch" mechanism. We propose that this mechanism represents a general mode of ligand binding for structurally related cell wall-anchored proteins of gram-positive bacteria.

[1]  V. Stojanoff,et al.  X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. , 1999, Science.

[2]  A. Kay,et al.  Chemotaxis for Human Monocytes by Fibrinogen‐derived Peptides , 1976, British journal of haematology.

[3]  T. Foster,et al.  Loss of Clumping Factor B Fibrinogen Binding Activity byStaphylococcus aureus Involves Cessation of Transcription, Shedding and Cleavage by Metalloprotease* , 2001, The Journal of Biological Chemistry.

[4]  G. Waksman,et al.  Structural basis of chaperone function and pilus biogenesis. , 1999, Science.

[5]  R. M. Donlan,et al.  Biofilms and device-associated infections. , 2001, Emerging infectious diseases.

[6]  C. Esmon,et al.  Thrombin Glu-39 restricts the P'3 specificity to nonacidic residues. , 1991, The Journal of biological chemistry.

[7]  R. Senior,et al.  Fibrinogen-derived peptide B beta 1-42 is a multidomained neutrophil chemoattractant. , 1988, Blood.

[8]  M. Höök,et al.  Staphylococcus aureus Expresses a Major Histocompatibility Complex Class II Analog (*) , 1995, The Journal of Biological Chemistry.

[9]  T. Foster,et al.  Surface protein adhesins of Staphylococcus aureus. , 1998, Trends in microbiology.

[10]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[11]  M. Palma,et al.  Extracellular Fibrinogen-binding Protein, Efb, fromStaphylococcus aureus Blocks Platelet Aggregation Due to Its Binding to the α-Chain* , 2001, The Journal of Biological Chemistry.

[12]  R. Senior,et al.  Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. , 1986, The Journal of clinical investigation.

[13]  D. Goldmann,et al.  Coagulase-negative staphylococci: role as pathogens. , 1999, Annual review of medicine.

[14]  H. Scheraga Chemical Basis of Thrombin Interactions with Fibrinogen a , 1986, Annals of the New York Academy of Sciences.

[15]  A. Kay,et al.  The Identification of Fibrinopeptide B as a Chemotactic Agent Derived from Human Fibrinogen , 1974, British journal of haematology.

[16]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[17]  M. Höök,et al.  SdrG, a Fibrinogen-binding Bacterial Adhesin of the Microbial Surface Components Recognizing Adhesive Matrix Molecules Subfamily from Staphylococcus epidermidis, Targets the Thrombin Cleavage Site in the Bβ Chain* , 2001, The Journal of Biological Chemistry.

[18]  M. Höök,et al.  Microbial adhesins recognizing extracellular matrix macromolecules. , 1994, Current opinion in cell biology.

[19]  R. Huber,et al.  The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution. , 1994, The Journal of biological chemistry.

[20]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[21]  S. Narayana,et al.  Structural Organization of the Fibrinogen-binding Region of the Clumping Factor B MSCRAMM of Staphylococcus aureus * , 2001, The Journal of Biological Chemistry.

[22]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[23]  S. Narayana,et al.  Crystallization of ClfA and ClfB fragments: the fibrinogen-binding surface proteins of Staphylococcus aureus. , 1999, Acta crystallographica. Section D, Biological crystallography.

[24]  M. Carson,et al.  A novel variant of the immunoglobulin fold in surface adhesins of Staphylococcus aureus: crystal structure of the fibrinogen‐binding MSCRAMM, clumping factor A , 2002, The EMBO journal.

[25]  S. Lord,et al.  The fibrinogen sequences that interact with thrombin , 1993 .

[26]  Y. Konishi,et al.  Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues. , 1996, Biochemistry.

[27]  G. Lina,et al.  The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis. , 2000, Microbiology.

[28]  I. Campbell,et al.  Pathogenic bacteria attach to human fibronectin through a tandem β-zipper , 2003, Nature.

[29]  Thomas C. Terwilliger,et al.  Automated MAD and MIR structure solution , 1999, Acta crystallographica. Section D, Biological crystallography.

[30]  M. Palma,et al.  Adherence of Staphylococcus aureus Is Enhanced by an Endogenous Secreted Protein with Broad Binding Activity , 1999, Journal of bacteriology.

[31]  B. Blombäck,et al.  Specificity of Thrombin and Its Action on Fibrinogen , 1986, Annals of the New York Academy of Sciences.

[32]  J. Schrenzel,et al.  Identification and Characterization of a Novel 38.5-Kilodalton Cell Surface Protein of Staphylococcus aureus with Extended-Spectrum Binding Activity for Extracellular Matrix and Plasma Proteins , 2001, Journal of bacteriology.

[33]  D. Eisenberg,et al.  Assessment of protein models with three-dimensional profiles , 1992, Nature.

[34]  R. Gaynes,et al.  Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States , 2000, Infection Control & Hospital Epidemiology.